MycoAsia promotes and strives for a high standard in publication ethics. 

Authors should declare the contribution of each participating author in the manuscript. Any disputes that may arise post-submission/ acceptance shall be dealt with according to the COPE guidelines.

Manuscripts which are already in consideration for publication in another journal should not be submitted to MycoAsia. Simultaneous submission of the same manuscript to multiple journals is unethical. Authors should not send manuscripts already published in another journal to MycoAsia.  

Authors shall respect the intellectual property rights of others and should not use any material in their manuscripts without obtaining necessary permission from owners of such materials/sources.

Authors shall provide an undertaking to declare if there are any conflicts of interest/ competing interests in the manuscript. 

MycoAsia promotes sharing data and biological materials mentioned in published papers within the rules and regulations of the countries involved. 

The Editorial Board would try to identify and prevent the publication of papers with suspected scientific misconduct. If any of the Editorial members of MycoAsia is found to be supporting unethical behaviour/ practices, the Editor-in-chief will eliminate him/ her from the Editorial Board.

Authors and readers are encouraged to report any research misconduct in published papers of MycoAsia. All complaints of scientific misconduct received by the Editorial Office shall be immediately looked into, and an interim reply will be given to the complainant within three working days. The final decision of the Editor-in-Chief on all such matters shall be communicated once the facts are established following the procedures prescribed by the COPE.

COPE guidelines are available at https://publicationethics.org/.

You can download the presentation slides of MycoAsia Publication Ethics Workshop conducted by Dr. Thomas Edison E. dela Cruz, Associate Editor of MycoAsia – Click here, and the video recording is available on YouTube.